tirzepatide when to increase dose dosage chart for weight loss Mounjaro (tirzepatide) - Diabetes &

GLP-1 agonists help you lose weight by: Although both work in the same way, semaglutide binds more strongly to GLP-1 receptors and lasts longer in the body than liraglutide [2]

Potential Side Effects of Semaglutide Like any medication, Semaglutide has potential side effects

Use of GLP-1 receptor agonists, including SOLIQUA 100/33, has been associated with gastrointestinal adverse reactions, sometimes severe [see Adverse Reactions (6)]

On August 27, 2025, the FDA approved the first generic version of liraglutide (Saxenda) for weight loss in adults and adolescents with obesity and adults with overweight and at least one weight-related comorbid condition

Multiple studies have demonstrated BPC-157s effects on tendon repair

GLP-1 RAs mitigate obesity, improve insulin sensitivity, and exert beneficial effects on sex hormone levels, glucose-lipid metabolism, and reproductive function in patients living with PCOS [28,40]